Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others > Other Targets

Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC12577 AC-263093 Featured
AC-263093 (AC263093) is a potent, functionally selective neuropeptide FF receptor type 2 (NPFFR2) agonist with pKi of 6.9.
More description
DC12492 N-(p-Amylcinnamoyl) anthranilic Acid (ACA) Featured
ACA is a cell permeable inhibitor of PLA2,reported to inhibit α-ketoisocaproic acid and glyceraldehyde-induced insulin secretion, as well as glucose-induced insulin secretion.
More description
DC9917 Acacetin Featured
Acacetin is an O-methylated flavone found in Robinia pseudoacacia (black locust), Turnera diffusa (damiana),Betula pendula (silver birch),and in the fern Asplenium normale.
More description
DC22280 Acarbose Featured
Acarbose is the first identified α-glucosidase inhibitor.
More description
DC9986 Acebilustat(ZK322) Featured
Acebilustat(ZK322) is a potent and selective leukotriene A4 hydrolase inhibitor.
More description
DC10592 ASL 601(Acecainide) Featured
Acecainide, also known as N-acetylprocainamide and ASL 601, is the N-acetylated metabolite of procainamide.
More description
DC10492 ACSS2 inhibitor Featured
ACSS2 inhibitor is a novel ACSS2 inhibitor.
More description
DC7997 ACTB-1003 Featured
ACTB-1003 is a potent inhibitor of FGFR1 with IC50 <10 nM in FGFR-1 biochemical assay; more information can be find in Patent WO/2007/064883A2, Example 12.
More description
DC10745 Adelmidrol Featured
Adelmidrol is an anti-inflammatory ethanolamide derivative of azelaic acid.
More description
DC8355 Adjudin (AF-2364) Featured
AF-2364, an analogue of Lonidamine (LND), had a contraceptive effect when orally administered to adult Sprague–Dawley rats.
More description
DC10623 AG-494 Featured
AG-494 is an inhibitor of epidermal growth factor receptor kinase with an IC50 value of 1 µM in HT-22 cells.
More description
DC9338 ALK inhibitor 1 Featured
ALK inhibitor 1 is a novel and selective inhibitor for the ALK kinase.
More description
DC9339 ALK inhibitor 2 Featured
ALK inhibitor 2 is a novel and selective inhibitor for the ALK kinase.
More description
DC10582 Diroximel Fumarete(ALKS-8700) Featured
ALKS-8700 also known as diroximel fumarate, is a prodrug of monomethyl fumarate in a controlled-release formulation that rapidly and efficiently converts to MMF in the body.
More description
DC5076 Alogliptin Benzoate Featured
Alogliptin is an orally administered, anti-diabetic drug in the DPP-4 inhibitor class. A randomized clinical trial reporting in 2011 aimed to determine the efficacy and safety of alogliptin versus placebo and voglibose among newly diagnosed Type 2 diabete
More description
DC10735 Alovudine Featured
Alovudine is a DNA polymerase subunit gamma-1 (POLG) inhibitor, shows promise for treating AML.
More description
DC9920 alpha-Hederin Featured
alpha-hederin is a water-soluble pentacyclic triterpenoid saponin, possessing several biological properties such as antispasmodic, moliscicidic, anthelmithic and inhibiting cell proliferation.
More description
DC23079 α-mangostin Featured
Alpha-Mangostin has neuroprotective, anti-cancer, antifungal, neuroprotective, renoprotective, antioxidant and anti-inflammatory activities.
More description
DC26001 Alprenolol Featured
Alprenolol is a non-selective beta blocker as well as 5-HT1A receptor antagonist.
More description
DC12656 Alrestatin Featured
Alrestatin is an AKR (aldose reductase) inhibitor, which attaches molecules to the active site of the NADP+/enzyme complex in a stacked formation.
More description
DC21483 PF03715455 Featured
PF-03715455 is a potent inhaled p38 MAPK inhibitor. PF-03715455 shows some selectivity for p38α over p38β with respective IC50 values of 0.88 and 23 nM. PF-03715455 potently inhibits LPS-induced TNFα production in human whole blood (IC50=1.7 nM). PF-03715455 has potential for the treatment of COPD (chronic obstructive pulmonary disease)[1][2].PF-03715455 is a moderate inhibitor of CYP1A2, CYP2C19, and CYP2D6 and a potent inhibitor of CYP’s 2C9 and CYP3A4[2].PF-03715455 treatment shows that the Vss and T1/2 are 0.19 L/kg, 1 hour, respectively[2]. Animal Model: Male CD Sprague Dawley rats (300-450 g)[2] Dosage: 1 mg/kg Administration: I.v. (Pharmacokinetic Analysis) Result: The Vss, and T1/2 were 0.19 L/kg, 1 hour, respectively.
More description
DC10412 AX20017 Featured
AX20017 is a small-molecule protein kinase G (PknG) inhibitor with an IC50 of 0.39 μM.
More description
DCAPI1343 Amorolfine HCl Featured
Amorolfine hydrochloride is a antifungal reagent.
More description
DC10533 PKM2 inhibitor(compound 3k) Featured
A novle PKM2 inhibitor inhibitor.
More description
DC10594 Tolcide 2230 Featured
An antimicrobial agent used as a substitute for chlorophenols
More description
DC20341 Ciliobrevin D Featured
Ciliobrevin D is a cell-permeable, reversible, specific inhibitor of cytoplasmic dynein, blocks dynein-dependent microtubule gliding and ATPase activity while sparing kinesin dependent cellular trafficking.
More description
DC32783 BAM15 Featured
BAM15 is a potent and selective mitochondrial uncoupler or protonophore. Chemical mitochondrial uncouplers are lipophilic weak acids that transport protons into the mitochondrial matrix via a pathway that is independent of ATP synthase, thereby uncoupling nutrient oxidation from ATP production. These uncouplers have potential for the treatment of diseases such as obesity, Parkinson’s disease, and aging.
More description
DC12254 UC-1728 Featured
UC-1728 is a potent rabbit soluble epoxide hydrolase (sEH) inhibitor, with an IC50 of 2 nM on rabbit liver.
More description
DC22569 BTTAA Featured
BTTAA is a Cu(I)-stabilizing ligand, whch performs potently with ubiquitin Glu18AzF.
More description
DC31451 CCS-1477(CBP-IN-1) Featured
CCS-1477 is a potent and selective p300/CBP bromodomain inhibitor, is targeted & differentiated from BET inhibitors in prostate cancer cell lines in vitro. Combination of CCS1477 & JQ1 resulted in a highly synergistic inhibitory effect on proliferation in normal 22Rv1 cells. Global gene expression analysis revealed significantly fewer altered genes after CCS1477 (27 up, 119 down) compared to JQ1 (196 up, 655 down).
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X